Package 46287-045-15

Brand: tadliq

Generic: tadalafil
NDC Package

Package Facts

Identity

Package NDC 46287-045-15
Digits Only 4628704515
Product NDC 46287-045
Product ID 46287-045_cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93
Description

150 mL in 1 BOTTLE (46287-045-15)

Marketing

Marketing Status
Marketed Since 2022-08-30
Brand tadliq
Generic tadalafil
Sample Package No

Linked Drug Pages (1)

TADLIQ ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["2613563", "2613569"], "spl_set_id": ["7a909b25-3772-403e-a5fe-e4a040293fb7"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["CMP Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 mL in 1 BOTTLE (46287-045-15)", "package_ndc": "46287-045-15", "marketing_start_date": "20220830"}], "brand_name": "TADLIQ", "product_id": "46287-045_cf6ec62b-5d5e-49ed-8d46-8a759d0e2b93", "dosage_form": "SUSPENSION", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "46287-045", "generic_name": "Tadalafil", "labeler_name": "CMP Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADLIQ", "active_ingredients": [{"name": "TADALAFIL", "strength": "20 mg/5mL"}], "application_number": "NDA214522", "marketing_category": "NDA", "marketing_start_date": "20220830", "listing_expiration_date": "20261231"}